The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
Authors
Keywords
-
Journal
Biomolecules
Volume 10, Issue 1, Pages 154
Publisher
MDPI AG
Online
2020-01-21
DOI
10.3390/biom10010154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Circulating Tissue Inhibitor of Metalloproteinases‐1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease
- (2019) Wolfgang Lieb et al. Journal of the American Heart Association
- Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
- (2019) Michele Provenzano et al. Frontiers in Cell and Developmental Biology
- Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
- (2019) Nitin A. Das et al. CELLULAR SIGNALLING
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies
- (2018) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oxidative stress – chronic kidney disease – cardiovascular disease: A vicious circle
- (2018) Verdiana Ravarotto et al. LIFE SCIENCES
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
- (2017) Kunihiro Matsushita et al. Lancet Diabetes & Endocrinology
- Epidemiology of low-proteinuric chronic kidney disease in renal clinics
- (2017) Luca De Nicola et al. PLoS One
- Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
- (2016) Navdeep Tangri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Update on Inflammation in Chronic Kidney Disease
- (2015) Oleh M. Akchurin et al. BLOOD PURIFICATION
- Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease
- (2015) Yalcin Solak et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease
- (2015) Esther Martinez-Aguilar et al. JOURNAL OF VASCULAR SURGERY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy
- (2015) Luca De Nicola et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The role of matrix metalloproteinases and neutrophil gelatinase-associated lipocalin in central and peripheral arterial aneurysms
- (2015) Raffaele Serra et al. SURGERY
- Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia
- (2015) Giovanni De Caridi et al. International Wound Journal
- Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
- (2015) Kunihiro Matsushita et al. Lancet Diabetes & Endocrinology
- Fibrosis-Related Biomarkers and Risk of Total and Cause-Specific Mortality
- (2014) Isha Agarwal et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Impact of BMI on Cardiovascular Events, Renal Function, and Coronary Artery Calcification
- (2014) Domenico Russo et al. BLOOD PURIFICATION
- Novel indicators of fibrosis-related complications in children with chronic kidney disease
- (2014) Kinga Musiał et al. CLINICA CHIMICA ACTA
- Subclinical Atherosclerosis Measures for Cardiovascular Prediction in CKD
- (2014) K. Matsushita et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men
- (2013) Johanna Helmersson-Karlqvist et al. ATHEROSCLEROSIS
- Collagenases and cracks in the plaque
- (2013) Peter Libby JOURNAL OF CLINICAL INVESTIGATION
- Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis
- (2011) Cory M. Yamashita et al. AMERICAN JOURNAL OF PATHOLOGY
- Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm
- (2011) Priscila Ramos-Mozo et al. ATHEROSCLEROSIS
- Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data
- (2011) R. M. Simon et al. BRIEFINGS IN BIOINFORMATICS
- Number of Endothelial Progenitor Cells in Peripheral Artery Disease as a Marker of Severity and Association with Pentraxin-3, Malondialdehyde-Modified Low-Density Lipoprotein and Membrane Type-1 Matrix Metalloproteinase
- (2011) Tetsuji Morishita et al. Journal of Atherosclerosis and Thrombosis
- Does Uremia Cause Vascular Dysfunction?
- (2011) Philippe Brunet et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
- (2011) Ron T. Gansevoort et al. KIDNEY INTERNATIONAL
- Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis
- (2011) Domenico Russo et al. KIDNEY INTERNATIONAL
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression
- (2011) Yang Lu et al. MOLECULES AND CELLS
- Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis
- (2011) Kimberly A. Czech et al. PEDIATRIC NEPHROLOGY
- Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study
- (2011) Jonas Hansson et al. PLoS One
- Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
- (2010) Chung Lim et al. Current Vascular Pharmacology
- Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction
- (2010) C.R. Ban et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease
- (2010) Blai Coll et al. KIDNEY INTERNATIONAL
- Inhibition of integrin-linked kinase blocks podocyte epithelial–mesenchymal transition and ameliorates proteinuria
- (2010) Young Sun Kang et al. KIDNEY INTERNATIONAL
- Systemic Levels of MMP2/TIMP2 and Cardiovascular Risk in CAPD Patients
- (2010) Krystyna Pawlak et al. NEPHRON CLINICAL PRACTICE
- Evaluation of role of doxycycline (a matrix metalloproteinase inhibitor) on renal functions in patients of diabetic nephropathy
- (2010) Hari Krishan Aggarwal et al. RENAL FAILURE
- Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm
- (2009) Jan H.N. Lindeman et al. CIRCULATION
- Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?
- (2009) M. Peiskerová et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage
- (2008) Davide Bolignano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Circulating Matrix Metalloproteinase-2 Is an Independent Correlate of Proteinuria in Patients with Chronic Kidney Disease
- (2008) Makio Nagano et al. AMERICAN JOURNAL OF NEPHROLOGY
- Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and Proteinuria
- (2008) Yingjian Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy
- (2008) Anneli Lauhio et al. ANNALS OF MEDICINE
- Chemical biology of tetracycline antibioticsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Systems and Chemical Biology, and has undergone the Journal's usual peer review process.
- (2008) Bijan Zakeri et al. Biochemistry and Cell Biology
- Increased Matrix Metalloproteinase 2 Activity in the Human Internal Mammary Artery Is Associated with Ageing, Hypertension, Diabetes and Kidney Dysfunction
- (2008) A.W. Chung et al. JOURNAL OF VASCULAR RESEARCH
- Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins
- (2008) Joseph D. Raffetto et al. JOURNAL OF VASCULAR SURGERY
- Pervanadate-induced shedding of the intercellular adhesion molecule (ICAM)-1 ectodomain is mediated by membrane type-1 matrix metalloproteinase (MT1-MMP)
- (2008) E. Essick et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
- (2007) Joseph D. Raffetto et al. BIOCHEMICAL PHARMACOLOGY
- Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients
- (2007) Krystyna Pawlak et al. THROMBOSIS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started